Tox Check

Expert-led videos and podcasts focused on identifying, monitoring, and managing treatment-related toxicities across oncology therapies.

Breast Cancer

View All

Toxicity check for PI3K/AKT inhibitor side effects in metastatic breast cancer with experts Dr. Emily Gallagher and Dr. Neil Iyengar.

Breast Cancer

01/06/2026

PI3K/AKT Inhibitor Side Effect Management in Metastatic Breast Cancer

Emily Gallagher, MD, PhDNeil Iyengar, MDRohit Gosain, MDRahul Gosain, MD, MBA

Advanced breast cancer research discussion featuring Dr. Stephanie Graff, Dr. Rohit Gosain, and Dr. Rahul Gosain on managing side effects of CDK4/6 inhibitors.

Breast Cancer

10/16/2025

Managing Side Effects of CDK4/6 Inhibitors in Breast Cancer

Stephanie Graff, MD, FACP, FASCORahul Gosain, MD, MBARohit Gosain, MD

GI Oncology

View All

Expert guidance on managing side effects of colorectal cancer therapies, featuring Dr. Rona Yaeger and colleagues, for improved patient care and treatment outcomes.

GI Oncology

05/06/2026

How to Manage Side Effects of Colorectal Cancer Therapies

Rona Yaeger, MDRahul Gosain, MD, MBARohit Gosain, MD

Managing side effects of anti-VEGF Bevacizumab and anti-EGFR Cetuximab and Panitumumab in cancer treatment, presented by OncUpdates.

GI Oncology

05/28/2025

Managing Side Effects of Panitumumab, Cetuximab, and Bevacizumab

Pashtoon Kasi, MD, MS

Managing side effects of pancreatic cancer treatment with expert insights from oncologists and latest research updates on ToxCheck.

GI Oncology

05/28/2025

Managing Toxicities of FOLFIRINOX and Nab-Paclitaxel Plus Gemcitabine

Midhun Malla, MDRachna Shroff, MD, MS, FASCO

GU Oncology

View All

Strategies to Minimize Side Effects in RCC Treatment for Oncology Professionals - OncUpdates.

GU Oncology

08/07/2025

Strategies to Minimize Side Effects in RCC Treatment

Sumanta Pal, MD, FASCORahul Gosain, MD, MBARohit Gosain, MD

Hematology

View All

Group photo of three doctors discussing CAR T-Cell Therapy in Multiple Myeloma, highlighting collaboration and adverse effects management.

Hematology

08/04/2026

CAR T-Cell Therapy in Multiple Myeloma: Managing Adverse Effects Through Collaboration

Caitlin Costello, MDJoshua Richter, MDRahul Gosain, MD, MBARohit Gosain, MD

Experts discussing targeted therapy strategies for managing toxicities in multiple myeloma treatment, featuring Dr. Hamza Hashmi, Dr. Cesar Rodriguez, Dr. Rohit Gosain, and Dr. Rahul Gosain.

Hematology

05/20/2026

Bispecific Therapy in Multiple Myeloma: Strategies for Managing Toxicities

Hamza Hashmi, MDCesar Rodriguez, MDRahul Gosain, MD, MBARohit Gosain, MD

Toxicity management in cancer treatment, featuring experts Dr. Fadi Haddad, Dr. Onyee Chan, Dr. Rahul Gosain, and Dr. Rohit Gosain, discussing side effects of Tyrosine Kinase Inhibitors in CML.

Hematology

11/11/2025

How to Manage Side Effects of Tyrosine Kinase Inhibitors in CML

Fadi Haddad, MDOnyee Chan, MDRahul Gosain, MD, MBARohit Gosain, MD

Lung Cancer

View All

Group photo of three medical professionals discussing BRAF and MEK inhibitor side effects in NSCLC, featuring Dr. Melissa Johnson, Dr. Rohit Gosain, and Dr. Rahul Gosain.

Lung Cancer

05/28/2026

BRAF and MEK Inhibitor Side Effects in BRAF V600E–Mutated NSCLC

Melissa Johnson, MDRahul Gosain, MD, MBARohit Gosain, MD

Expert discussion on managing side effects of EGFR inhibitors in non-small cell lung cancer (NSCLC) with Dr. Azam Farooqi, Dr. Joshua Sabari, Dr. Rohit Gosain, and Dr. Rahul Gosain.

Lung Cancer

05/18/2026

How To Manage Side Effects of EGFR Inhibitors in NSCLC

Azam Farooqui, MDJoshua Sabari, MDRahul Gosain, MD, MBARohit Gosain, MD

Toxicity awareness in novel antibody-drug conjugates and NSCLC, featuring expert insights from Dr. Jacob Sands, Dr. Rohit Gosain, and Dr. Rahul Gosain on key adverse effects and safety considerations.

Lung Cancer

01/02/2026

Key Adverse Effects of Novel Antibody-Drug Conjugates in NSCLC

Jacob Sands, MDRahul Gosain, MD, MBARohit Gosain, MD

Optimizing ROS1 inhibitor therapy in NSCLC with insights from Dr. Estelamari Rodriguez and colleagues for cancer research and targeted lung cancer treatment.

Lung Cancer

11/15/2025

Optimizing ROS1 Inhibitor Therapy in NSCLC

Estelamari Rodriguez, MD, MPHRohit Gosain, MDRahul Gosain, MD, MBA

Expert panel discussing management of anti-EGFR toxicities in NSCLC treatment strategies.

Lung Cancer

05/28/2025

How to Manage Anti-EGFR Toxicities in NSCLC

Gilberto Lopes, MD